Gregory S. Martini
CIK: 0002053936
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 18, 2026KYTX
Kyverna Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
325K shares- - Mar 10, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct136.6K shares- - Feb 24, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct11.5K shares at avg. $3.66$42K - Feb 23, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct10.5K shares at avg. $3.81$40K - Aug 11, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct1.3K shares at avg. $0.84$1K - Feb 10, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct12.1K shares at avg. $1.76$21K - Jan 27, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct111.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 18, 2026 |  KYTX Kyverna Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 325,000 | - | - | Direct |
| Mar 10, 2026 |  IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 136,612 | - | $0 | Direct |
| Feb 24, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 11,457 | $3.66 | $41,933 | Direct |
| Feb 23, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 10,487 | $3.81 | $39,955 | Direct |
| Aug 11, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 1,265 | $0.84 | $1,063 | Direct |
| Feb 10, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 12,052 | $1.76 | $21,212 | Direct |
| Jan 27, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 111,111 | - | $0 | Direct |
1-7 of 7 transactions
About Martini Gregory S.
Martini Gregory S. (SEC CIK 0002053936) files insider reports with the SEC as Chief Financial Officer of Kyverna Therapeutics, Inc. (KYTX) and Chief Financial Officer of IRONWOOD PHARMACEUTICALS INC (IRWD).
Signal8 holds 8 ownership filings by Martini Gregory S. (2 Form 3, 6 Form 4), filed between Jan 29, 2025 and May 20, 2026. Those filings report 7 transactions, from Jan 27, 2025 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Martini Gregory S.'s filings is in BOSTON, MA.
Recent filings by Martini Gregory S.
- May 18, 2026: Grant or award of KYTX derivative securities (Form 4, code A).
- Mar 10, 2026: Grant or award of IRWD shares (Form 4, code A).
- Feb 24, 2026: Open-market sale of IRWD shares (Form 4, code S).
- Feb 23, 2026: Open-market sale of IRWD shares (Form 4, code S).
- Aug 11, 2025: Open-market sale of IRWD shares (Form 4, code S).
Other insiders filing for Kyverna Therapeutics, Inc. (KYTX)
- CLARK IAN T, Director
- Cohen Fred E, Director
- SEIDENBERG BETH C, Director
- Shaw Christi, Executive Chairperson
- Aktar Mert, Director
- Dac Nadia, Chief Commercial Officer